Teva

Page 2 of 2

J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance

Biotech Stocks Crashed and Nobody Knows Why

By
January 29, 2016
Pfizer employees inside of a laboratory at Pfizer's research and development facility in Cambridge, Massachusetts, U.S., on Monday, Oct. 26, 2015. Photographer: Scott Eisen/Bloomberg *** Local Caption ***
Finance

Why Pfizer Is Headed for Splitsville After Allergan Merger

By
November 19, 2015
14th Annual Elton John AIDS Foundation An Enduring Vision Benefit - Show
Finance

Why Mylan Just Lost The Largest Hostile Takeover Battle Ever

By
November 13, 2015
Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
Health

Mylan’s Hostile Bid for Perrigo Fails

By
November 13, 2015
A Teva Pharmaceutical Industries factory in Jerusalem, Israel.
Finance

The real reasons for the pharma merger boom

By
July 28, 2015
Inside Teva Pharmaceuticals Headquarters
Commentary

Teva buys Allergan: 3 reasons why it’s a blockbuster deal

By
July 27, 2015

Most Popular